| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 12 |
| 1 | METHOTREXATE | 8 |
| 2 | METHOTREXATE SODIUM | 8 |
| 3 | AZATHIOPRINE | 6 |
| 4 | PREDNISONE | 6 |
| 5 | BLEOMYCIN SULFATE | 5 |
| 6 | PREDNISOLONE | 5 |
| 7 | PREDNISOLONE ORAL | 5 |
| 8 | PREDNISOLONE ORAL SOLUTION | 5 |
| 9 | DACARBAZINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 1 | DACARBAZINE | 4 | 0.0005 |
| 2 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 3 | BLEOMYCIN SULFATE | 5 | 0.0005 |
| 4 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 5 | MESNA INJECTION | 1 | 0.0001 |
| 6 | MESNA | 1 | 0.0001 |
| 7 | MESALAMINE | 3 | 0.0001 |
| 8 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| 9 | ZONISAMIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 1 | Corticosteroid [EPC] | 12 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| 3 | Purine Antimetabolite [EPC] | 6 |
| 4 | Alkylating Drug [EPC] | 5 |
| 5 | Atypical Antipsychotic [EPC] | 4 |
| 6 | Aminosalicylate [EPC] | 3 |
| 7 | Platinum-based Drug [EPC] | 3 |
| 8 | Topoisomerase Inhibitor [EPC] | 3 |
| 9 | Anti-epileptic Agent [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 1 | Purine Antimetabolite [EPC] | 6 | 0.0001 |
| 2 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 5 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 8 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Cholinergic Nicotinic Agonist [EPC] | 1 | 0.0000 |